0001628280-24-008955.txt : 20240305 0001628280-24-008955.hdr.sgml : 20240305 20240305164325 ACCESSION NUMBER: 0001628280-24-008955 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240304 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dugan Margaret CENTRAL INDEX KEY: 0001909734 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39206 FILM NUMBER: 24721472 MAIL ADDRESS: STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN) STREET 2: 94 SOLARIS AVE, CAMANA BAY, PO BOX 1348 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Schrodinger, Inc. CENTRAL INDEX KEY: 0001490978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 954284541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1540 BROADWAY STREET 2: 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 503-299-1150 MAIL ADDRESS: STREET 1: 1540 BROADWAY STREET 2: 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 wk-form4_1709674967.xml FORM 4 X0508 4 2024-03-04 0 0001490978 Schrodinger, Inc. SDGR 0001909734 Dugan Margaret C/O SCHRODINGER, INC. 1540 BROADWAY, 24TH FLOOR NEW YORK NY 10036 0 1 0 0 Chief Medical Officer 0 Stock Option (right to buy) 25.24 2024-03-04 4 A 0 60000 0 A 2034-03-04 Common Stock 60000 60000 D The option was granted on March 4, 2024. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028. /s/ Donald Shum, as attorney-in-fact for Margaret Dugan 2024-03-05